Walleye Trading
ICPT

Walleye Trading’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Walleye Trading’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,300
Closed -$37K – 6075
2021
Q4 		$37K Sell
2,300
-23,500
-91% -$396K ﹤0.01% 4754
2021
Q3 		$383K Sell
25,800
-1,100
-4% -$17.6K ﹤0.01% 3196
2021
Q2 		$537K Buy
26,900
+15,700
+140% +$311K ﹤0.01% 2830
2021
Q1 		$258K Buy
11,200
+11,000
+5,500% +$307K ﹤0.01% 3395
2020
Q4 		$5K Buy
+200
New +$6.63K ﹤0.01% 4488
2020
Q2 		– Sell
-6,800
Closed -$428K – 4727
2020
Q1 		$428K Buy
6,800
+4,600
+209% +$413K ﹤0.01% 1983
2019
Q4 		$273K Sell
2,200
-4,000
-65% -$358K ﹤0.01% 2901
2019
Q3 		$411K Buy
+6,200
New +$416K ﹤0.01% 2331
2019
Q2 		– Sell
-1,700
Closed -$190K – 4628
2019
Q1 		$190K Buy
+1,700
New +$186K ﹤0.01% 3066
2018
Q4 		– Sell
-2,700
Closed -$341K – 5486
2018
Q3 		$341K Buy
+2,700
New +$286K ﹤0.01% 3295

Other funds holding ICPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Walleye Trading's ICPT Position: Q1 2022 in Review

Walleye Trading sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q1 2022, closing a stake of 15,155 shares — an estimated $247K sold.

Walleye Trading first reported a position in ICPT in Q1 2019 and held it in 7 quarters. The position peaked at $269K in Q1 2019. 148 funds tracked by Wall St. Rank hold ICPT as of Q1 2022.

  • Walleye Trading reported no remaining Intercept Pharmaceuticals, Inc. position as of Q1 2022 after selling out during the quarter.
  • Walleye Trading sold 15,155 Intercept Pharmaceuticals, Inc. shares in Q1 2022, an estimated $247K.
  • Walleye Trading first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2019 and held it in 7 quarters.
  • Walleye Trading's Intercept Pharmaceuticals, Inc. position peaked at $269K in Q1 2019.
  • 148 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q1 2022.

Based on Walleye Trading's 13F filing for Q1 2022, filed 16 May 2022.